Video Experimental Relacionado
Updated: Apr 13, 2026
13:32
High Content Screening in Neurodegenerative Diseases
Published on: January 6, 2012
17.6K
Un sistema eficaz para el desarrollo de fármacos moduladores de la senescencia utilizando análisis cuantitativos de
Yajie Hu1, Xueqi Xue1, Tian Han1
1Discovery Biology Unit, WuXi Biology, WuXi AppTec Ltd., Shanghai, China.
Communications biology
|August 30, 2025
Resumen
Este estudio introduce un nuevo sistema de análisis de alto contenido para evaluar los marcadores de senescencia celular, mejorando el desarrollo de fármacos para la investigación del envejecimiento. El sistema permite el cribado de alto rendimiento de agentes senomorfos, senolíticos e inductores de seno.
Área de la Ciencia:
- Biogerontología
- Descubrimiento de drogas
- Biología celular
Sus antecedentes:
- La senescencia celular es crucial en la investigación del envejecimiento y el desarrollo de fármacos anti-senescencia.
- Los ensayos actuales de beta-galactosidasa asociada a la senescencia (SA-β-gal) no son cuantitativos y requieren mucha mano de obra.
- Existe la necesidad de métodos eficientes y de alto rendimiento para evaluar los moduladores de senescencia.
Objetivo del estudio:
- Desarrollar y validar un sistema de análisis múltiple de alto contenido para el cribado de alto rendimiento de los moduladores de senescencia.
- Permitir la evaluación cuantitativa de los agentes senomorfos, senolíticos y inductores del seno.
- Para facilitar el desarrollo de fármacos para terapias anti-senescencia.
Principales métodos:
- Desarrollo de un sistema de análisis múltiple de alto contenido.
- Cribado de alto rendimiento de los moduladores de senescencia en los fibroblastos.
- Determinación de los valores de IC50 o EC50 para los moduladores de senescencia.
Principales resultados:
- El sistema desarrollado es eficaz y reproducible para evaluar los moduladores de senescencia.
- El sistema permite la evaluación simultánea de agentes senomorfos, senolíticos y inductores del seno.
- Se identificaron nuevas entidades moleculares que modulan la senescencia inducida por MMC, lo que sugiere nuevos objetivos celulares.
Conclusiones:
- El nuevo sistema de análisis de alto contenido avanza significativamente en la detección y evaluación de los moduladores de senescencia.
- Esta plataforma es esencial para acelerar el desarrollo de fármacos en la investigación sobre el envejecimiento y la terapia antienvejecimiento.
- La identificación de nuevas entidades moleculares pone de relieve el potencial del sistema para descubrir nuevos objetivos terapéuticos.
Videos de Conceptos Relacionados
01:24Rational Dosage Regimen: Maintenance Dose and Loading Dose
5.9K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
5.9K
01:28Dosage Regimens: Designs and Approaches
566
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
566
01:15Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
355
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
355
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
369
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
369
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
317
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
317
01:28Methods of Medium Optimization
63
Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...
63